cyclic GMP measurement (lab test)

Known as: cGMP Measurement, Cyclic Guanosine Monophosphate, Cyclic Guanosine Monophosphate Measurement 
The determination of the amount of cyclic guanosine 3,5-monophosphate present in a sample.
National Institutes of Health

Related topics

Related topics

4 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium TerminologyCyclic GMP

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals.
BACKGROUND Anthocyanins have been shown to improve endothelial function in animal models. However, whether these compounds have… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome.
PURPOSE We tested for associations between urine markers, bladder biopsy features and bladder ulcers in interstitial cystitis… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
Reduction of myocardial infarct size by fluvastatin.
Statins have a variety of cardioprotective properties following chronic treatment. In contrast, little is known about the acute… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2003
2003
A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits.
We have recently found evidence for impairment of nitric oxide (NO) formation and induction of oxidative stress in residents of… (More)
Is this relevant?
2002
2002
Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats
The forced swimming test (FST) has been extensively used as a screening model for new antidepressant agents. It has been shown… (More)
Is this relevant?
2001
2001
Identification and regulation of human PDE5A gene promoter.
PDE5A gene encodes type 5 phosphodiesterase (PDE5), the principal cGMP-catalyzing enzyme in the penis and the primary target of… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Frequency of mutations in the gene encoding the alpha subunit of rod cGMP-phosphodiesterase in autosomal recessive retinitis pigmentosa.
PURPOSE To determine the mutation spectrum of the PDE6A gene encoding the alpha subunit of rod cyclic guanosine monophosphate… (More)
Is this relevant?
1998
1998
Inhibition of proximal tubular fluid absorption by nitric oxide and atrial natriuretic peptide in rat kidney.
Atrial natriuretic factor (ANF) and nitric oxide (NO) stimulate production of guanosine 3',5'-cyclic monophosphate (cGMP) and are… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes.
Whether organic nitrates are bioactivated to NO in cardiac muscle cells and may thus directly affect cardiac contractile function… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.
OBJECTIVE To document regional plasma concentrations of brain natriuretic factor (BNF) and their relations to concurrent… (More)
  • figure 1
  • figure 2
Is this relevant?